Moderna’s RSV shot wins FDA approval for use in older adults ...Middle East

NY Times News - News
Moderna’s RSV shot wins FDA approval for use in older adults
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots. The US Food and Drug Administration approved Cambridge, Massachusetts-based Moderna’s vaccine against respiratory syncytial virus, a flu-like illness that affects elderly adults and babies most severely, according to a statement Friday. The decision had earlier been expected by May 12, and was delayed because of “administrative constraints” at the agency, Moderna said earlier this month.  Moderna’s shot, called mRESVIA, was cleared for use in adults 60 and older and will compete with products tha

Hence then, the article about moderna s rsv shot wins fda approval for use in older adults was published today ( ) and is available on NY Times News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moderna’s RSV shot wins FDA approval for use in older adults )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News